← Leaderboards
Christy Hagan
University Of Minnesota
$1,691,746
Attributed
$1,927,885
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $519K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,927,885 · 4
By mechanism
R00$747,000 · 1
P01$518,958 · 1
R21$472,279 · 1
K99$189,648 · 1
Top collaborators
- Zachary Conrad Hartman2 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Carol Ann Lange$17,870,830
- Carol Ann Sartorius$5,515,814
- Douglas Yee$35,505,227
- Yanaira Alonso Caraballo$662,230
- Thu Ha Truong$751,817
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProgesteroneHormone TherapyMammary NeoplasmsMalignant Breast NeoplasmSignal TransductionProgesterone ReceptorsMediatingEstrogen ReceptorsEventUterusTumor ProgressionGenesBasePreventMammary GlandBreastTissuesBiologyBinding SitesGenome-WideGene TargetingCancerousGenetic Transcription
Grant awards (8)
Evaluating the potential of progestins to promote the development or progression of mammary tumors$518,958
P01 · FY2025 · CA · contact PI
Targeting the Progesterone Receptor as a Novel Means to Increase Efficacy of Immune Checkpoint Inhibitors in Hormone Receptor Positive Breast Cancer$216,691
R21 · FY2023 · CA · contact PI
Targeting the Progesterone Receptor as a Novel Means to Increase Efficacy of Immune Checkpoint Inhibitors in Hormone Receptor Positive Breast Cancer$255,588
R21 · FY2022 · CA · contact PI
CK2-dependent phosphorylation of Progesterone Receptors mediates proliferative signaling in breast cancer$249,000
R00 · FY2017 · CA · contact PI
CK2-dependent phosphorylation of Progesterone Receptors mediates proliferative si$249,000
R00 · FY2016 · CA · contact PI
CK2-dependent phosphorylation of Progesterone Receptors mediates proliferative si$249,000
R00 · FY2015 · CA · contact PI
CK2-dependent phosphorylation of Progesterone Receptors mediates proliferative si$97,538
K99 · FY2013 · CA · contact PI
CK2-dependent phosphorylation of Progesterone Receptors mediates proliferative si$92,110
K99 · FY2012 · CA · contact PI